Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, according to a groundbreaking study from Klick Labs that combines voice technology with artificial intelligence in a major step forward in diabetes detection.
Roivant announces study win in eye disease for Pfizer asset, plans $1.5B share buyback
Roivant has found a use for its extra cash, and is revealing the latest data from the big pharma relationship that helped generate those funds.
April 3, 2024